Oncology/Hematology

Other Cancers

Latest AI and machine learning research in other cancers for healthcare professionals.

8,873 articles
Stay Ahead - Weekly Other Cancers research updates
Subscribe
Browse Categories
Showing 1-20 of 8,873 articles

Circulating NSUN6 serves as a prognostic biomarker for early metastasis in HCC via hippo pathway modulation.

BACKGROUND: Portal vein tumor thrombus is a lethal complication of HCC for which effective biomarkers are urgently needed. METHODS: Through proteomic profiling, functional and mechanistic assays, and machine learning-based evaluation of serum NSUN6 in 472 HCC patients with external validation (n = 98), we characterized an epitranscriptomic regulator of HCC metastasis. RESULTS: NSUN6 was downregula...

Jul 17 2026 42464346

The evolving bioinformatic approaches to identifying genetic targets of promise in cancers.

INTRODUCTION: The search for actionable genetic targets in cancer has evolved substantially over the past decade. Earlier approaches were focused on single genes or individual molecular alterations, but this is insufficient to capture tumor complexity in vivo. Cancer is influenced not only by genomic changes but also by transcriptional plasticity, epigenetic regulation, protein activity, metabolic...

Jul 17 2026 42464692
Prediction of Central Lymph Node Metastasis in Papillary Thyroid Carcinoma Using Multi-Ultrasound Radiomics of Intratumoral and Peritumoral Regions.

OBJECTIVE: The aim of this study was to integrate multimodal intratumoral and peritumoral ultrasound radiomic features with clinical data to construct...

Jul 17 2026 42467019
Deep learning-based automated assessment of alveolar bone loss in CBCT for periodontitis.

OBJECTIVES: This study aimed to develop and validate a CBCT-based automated system for assessing radiographic alveolar bone loss (RBL) to improve the ...

Jul 17 2026 42467296
Is adenosine signalling entering the precision medicine era? From receptor pharmacology to patient stratification.

Over the past three decades, adenosine signalling has emerged as a fundamental regulatory system controlling immune responses, tissue homeostasis, met...

Jul 17 2026 42467297
Metabolic signatures of triple-negative breast cancer.

Triple-negative breast cancer (TNBC), being one of the most aggressive subtypes of breast malignancies, is characterized by poor prognosis and limited...

Jul 17 2026 42467335
Deep learning reveals FLAD1-mediated mitochondrial metabolic reprogramming in hypoxic tumors.

Hypoxia, a hallmark of solid tumors, drives malignant progression and represents a major therapeutic challenge. Metabolic reprogramming induced by hyp...

Jul 17 2026 42467529
Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer.

Late distant recurrence (DR) remains a persistent risk in hormone receptor-positive (HR+) early breast cancer after completion of 5 years of endocrine...

Jul 17 2026 42467849
Spatial architecture of tertiary lymphoid structures represents an independent prognostic dimension in hepatocellular carcinoma.

BACKGROUND AND AIMS: Tertiary lymphoid structures (TLS) are associated with heterogeneous outcomes in hepatocellular carcinoma (HCC), but whether thei...

Jul 17 2026 42468992
Multimodal Deep Fusion of Ultrasound Images and Clinical Factors for Pre-operative Prediction of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma.

OBJECTIVE: Lateral cervical lymph node metastasis (LLNM) is missed in up to 30% of papillary thyroid carcinoma (PTC) patients pre-operatively, leading...

Jul 17 2026 42469052
Integrated bibliometric and machine learning analyses identify candidate autophagy related therapeutic targets for prostate cancer.

PURPOSE: Autophagy is increasingly recognized as a promising therapeutic target in prostate cancer (PCa), yet its research landscape has not been syst...

Jul 17 2026 42469499
Machine learning prognostication in nasopharyngeal carcinoma: a european multicentre analysis of survival and risk of second malignancy.

INTRODUCTION: Nasopharyngeal carcinoma (NPC) is rare in Europe, and emerging data suggest poorer outcomes in Caucasian patients compared with Asian po...

Jul 17 2026 42463918
Glycosylation-related gene risk model and functional validation of OSTC and TUBA1C in lung adenocarcinoma.

INTRODUCTION: OSTC and TUBA1C drive the malignant progression of lung adenocarcinoma (LUAD) through the modulation of N-glycosylation and the PI3K/AKT...

Jul 16 2026 42464299
A USP15/KRT17-associated 13-gene prognostic cluster and functional validation in EGFR-mutant lung adenocarcinoma.

BACKGROUND: EGFR-mutant lung adenocarcinoma (LUAD) exhibits significant prognostic heterogeneity despite the efficacy of tyrosine kinase inhibitors. T...

Jul 16 2026 42458519
Cancer Vaccine Development: Toward Artificial Intelligence-Assisted Personalized Cell Membrane Nanovaccine.

Cancer vaccines are an attractive immunotherapeutic approach, and numerous clinical trials are ongoing. However, most candidates have not achieved sta...

Jul 16 2026 42460750
Precision Oncology in Northern Germany - Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards.

The expanding availability of multi-omics profiling and advances in artificial intelli-gence (AI) and machine learning (ML) are changing precision onc...

Jul 16 2026 42461906
Evaluating Large Reasoning Models Versus Human Multidisciplinary Teams in Lung Cancer Decision-Making: Real-World Study.

BACKGROUND: Large language models (LLMs) and large reasoning models (LRMs) have shown excellent performance on medical benchmarks, although evaluation...

Jul 16 2026 42461960
Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAF.

The therapeutic landscape of colorectal cancer (CRC) has evolved with the identification of molecular subtypes, including mismatch repair-deficient/mi...

Jul 16 2026 42462280
Artificial intelligence-assisted detection and optical differentiation of colorectal lesions in Lynch syndrome surveillance (CADLY2): a multicentre, open-label, randomised controlled superiority trial.

BACKGROUND: Artificial intelligence (AI)-based computer-aided detection (CADe) systems improve adenoma detection in average-risk colorectal cancer scr...

Jul 16 2026 42462747
Browse Categories